Fast Moving Stocks: Owens Realty Mortgage, Inc. (NYSEMKT:ORM), Huttig Building Products Inc. (NASDAQ:HBP), Penn West Petroleum Ltd. (NYSE:PWE), Halozyme Therapeutics, Inc.

Owens Realty Mortgage, Inc. (NYSEMKT:ORM) announced the tax treatment for ORM’s dividends on its common stock (CUSIP #690828108) for calendar year 2015.

Owens Realty Mortgage, Inc. (NYSEMKT:ORM) belongs to Financial sector. Its net profit margin is 85.10% and weekly performance is 6.21%. On last trading day company shares ended up at $15.40. Owens Realty Mortgage, Inc. (NYSEMKT:ORM) distance from 50-day simple moving average (SMA50) is 11.22%.

On 25 February, Huttig Building Products Inc. (NASDAQ:HBP) reported financial results for the fourth quarter and year ended December 31, 2015. Net sales in the fourth quarter of 2015 were $155.4 million, representing a 7% increase over net sales of $145.2 million for the prior year’s fourth quarter. Full year 2015 net sales were $659.6 million, representing a 6% increase over prior year net sales of $623.7 million.

Huttig Building Products Inc. (NASDAQ:HBP) shares increased 2.03% in last trading session and ended the day at $3.51. HBP Gross Margin is 20.00% and its return on assets is 13.50%. Huttig Building Products Inc. (NASDAQ:HBP) quarterly performance is -4.88%.

On 16 February, Penn West Petroleum Ltd. (NYSE:PWE) has reached agreements to settle a bevy of class-action lawsuits stemming from accounting. The settlement in the Canadian and U.S. cases will be fully funded by the company’s insurance, meaning its cash resources and financial position won’t take a hit.

Penn West Petroleum Ltd. (NYSE:PWE) belongs to Basic Materials sector. Its weekly performance is 5.52%. On last trading day company shares ended up at $0.98. Penn West Petroleum Ltd. (NYSE:PWE) distance from 50-day simple moving average (SMA50) is 23.50%.

On 29 February, Halozyme Therapeutics, Inc. (NASDAQ:HALO) reported Q4 EPS of $0.03, $0.11 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $52.2 million versus the consensus estimate of $42.06 million.

Halozyme Therapeutics, Inc. (NASDAQ:HALO) shares moved up 7.50% in last trading session and ended the day at $8.74. HALO Gross Margin is 76.10% and its return on assets is -25.50%. Halozyme Therapeutics, Inc. (NASDAQ:HALO) quarterly performance is -51.28%.

SINA Corporation (NASDAQ:SINA) will announce its unaudited financial results for the fourth quarter 2015 after the close of market on Wednesday, March 2, 2016. Following the announcement, SINA’s management team will host a conference call from 9:10 p.m. –9:50 p.m. Eastern Time on March 2, 2016 (or 10:10 a.m. — 10:50 a.m. Beijing Time on March 3, 2016) to present an overview of the Company’s financial performance and business operations.

On 01 March, SINA Corporation (NASDAQ:SINA) shares moved up 1.15% and was closed at $43.21. SINA EPS growth in last 5 year was -18.70%. SINA Corporation (NASDAQ:SINA) year to date (YTD) performance is -12.53%.

Leave a Reply

Your email address will not be published. Required fields are marked *